肝移植的禁忌证和危险因素
2012-04-01 01:28:56 来源: 作者: 评论:0 点击:
一、禁忌证
如果病人合并有下列疾病,应视为手术禁忌证。
(1) 血清中人类免疫缺陷病毒(HIV)阳性。
(2) 肝外恶性肿瘤。
(3) 胆管癌。
(4) 严重的心肺疾病。
(5) 未控制的全身性感染。
(6) 其他脏器功能衰竭。
(7) 心理学方面的不适应。
二、危险因素
肝移植的主要危险因素包括:年龄偏大、肌营养不良、昏迷、腹水、活动性出血和既往有腹部手术史等。表3-1为Pittsburgh的术前评估表,可用来粗略预测肝移植术后病人的存活率。
表3-1 肝移植受体术前评估表
分数表现 分数表现
昏迷6术中为昏迷状态腹水2难控制型
2ⅢⅣ期昏迷1可控制型
1间歇性意识不清0无
0无肝性脑病其他2胆红素300μmol/L
肌营养不良2重度肌营养不良1曲张静脉出血
1轻度肌营养不良1胆管系统感染
0无肌营养不良1自发性腹膜炎
既往手术史2多次胆管再建手术2年龄大于40岁
2门腔静脉分流术1胆红素100μmol/L
1每次开腹术1PT15 s
0无
本表应用比分累计法,0-3分表示低危病人,如果等于或高于7分,意味着存在着比3分病人高1倍的危险性。单一的因素如术后出血等,与术后病人的存活率也明显相关。既往腹有手术史,特别是胆管手术史,将明显增加手术的难度。
参考文献
1.Feray C,Zignergo AL,Samuel D et al.Persistent hepatitis Bvirus infetion of mononuclear blood cells without concomitant infection.The liver transplantation model.Transplantation,1990,49:1155
2.Pemetris AJ ,Todo S, Van Thiel Dhet al.Evolution of hepatitis B virus liver disease after hepatic replacement.Practical and theoretical consideration.Am J Pathol,1990,137:667
3.O’Grady JG,Willians R.Liver transplantation for viral hepatitis .Br Med Bull.1990,46:481
4.Mazzaferro V,Regalia E,Montalto F et al.Risk of HBV reinfection afeter liver transplantation in HbsAg-positive cirrhosis.Primary hepatocellular carcinoma is not a predictor for HBV recurrence.Liver ,1996,16:117
5.Marsman WA,Wiesher RH,Batts KP et al.Fulminant hepatitis Bvirus:recurrence after liver transplantation in two patients also infected with hepatitis delta virus.Hepatology,1997,25:434
6.Hart J.Busuttil RW,Lewm KJ.Disease recurrence following liver transplantation.Am J Surg Pathol.1990,14(Suppl1):79
7.Martin P,Munoz SJ,DiBisceglia AM et al.Recurrence of hepatitis Cvirus infection after orthotopic liver transplantation.Hepatology,1991,13:719
8.Gane EJ,Portinann BC,Waoumov NV et al .Long-term outcome of hepatitis Cinfection after liver transplantation.N Engl Med,1996,334:815
9.Baber KH,Dalley G,Bahr MJ et al.Long-term outcome of hepatitis C virus infection after liver transplatation .Hepatology,1997,25 :202
10.Terrault NA,Zhou S,Combs Cet al.Prophylaxis in liver transplant recipient using a fixed dosing schedule of hepatitis Bimmunoglobulin.Hepatology,1996,24:1327
11.Van Thiel DH,Bonet H,Gavaler J et al ,Effect of alcohol use on allograft liver transplantation for alcoholic liver disease.Alcohol Chin Exp Res,1995,19:1151
12.Maddrey WC.Bone disease in patients with primary biliary cirrhosis.Prog Liver Dis,1990,9:537
13.Shapiro JM,Smith H,Schaffner F.Serum bilirubin: a prognostic factor in primary biliary cirrhosis.Gut,1979,20:137
14.Mentna G,Giostra E,Rubbia L et al .Follow-up and result of liver transplantation of primary biliary cirrhosis.Swiss Surg,1996,3:116
15.Knoop M,Bechstein Wo,Schrem H et al.Chinical significance of recurrent primary billiary cirrhosis after liver transplantation .Transpl Int,1996,9(Suppl 1):S115
16.Sternlieb I.Wilson’s disease:indication for liver transplantation.Hepatology,1984,4:155
17.Exquive CO,Marino IR,Fioravanti V et al.Liver transplantation formetabolic disease of the liver,Gastroenterol Clin N Am,1988,17:167
18. Ismail T,Angrisani L,Gunson BK et al,Primary hepatic malignancy:The role of liver transplantation,Br J Surg,1990,77:983
19.Hoofnagle JH,Carithevs RC Jr,Shapiro Cet al.Fulminant hepatic failure:summary of a workshop.Hepatology,1995,21:240
20.Williams R,Wendon J.Indication for orthotopic liver transplantation in fulminant liver failure.Hepatology,1994,20:1.
21.Ludwing J,LaRusso NF,Wiesner RH.The syndrome of primary sclerosing cholangitis.Prog Liver Dis,1990,9:555
22 .Rosen CB,Nagorney DM,Wiesner RH et al.Cholangiocarcinoma complicating primary sclerosing cholangitis .Ann Surg,1991,213:21
23.Olsson R,Panielsson ,A,Jarnerot G et al .Prevalence of primary sclerosing cholangitis in patients with ulcerative colitis.Gastroenterology,1991,11:1319
24.Higashi H,Yanaga K,Marsh JW et al.Development of colon cancer after transplantation for primary sclerosing cholangitis associated with ulcerative colitis.Hepatology,1990,11:477
25.Alayoglu M,Stratta RJ,Sollinger HW .Liner transplantation in infans and children.J Pediatr Surg,1989,24:70
26.Salerno F,Borroni G,Moser Pet al .Prognostic value of the galactose test in predicting survival of patients with cirrhosis evaluated for liver transplantation A prospective multicenter Italian study.AISF Group for the Study of Liver Transplantation.Association Italiana per lo Studio del Fegato.Hepatol.1996,25474
如果病人合并有下列疾病,应视为手术禁忌证。
(1) 血清中人类免疫缺陷病毒(HIV)阳性。
(2) 肝外恶性肿瘤。
(3) 胆管癌。
(4) 严重的心肺疾病。
(5) 未控制的全身性感染。
(6) 其他脏器功能衰竭。
(7) 心理学方面的不适应。
二、危险因素
肝移植的主要危险因素包括:年龄偏大、肌营养不良、昏迷、腹水、活动性出血和既往有腹部手术史等。表3-1为Pittsburgh的术前评估表,可用来粗略预测肝移植术后病人的存活率。
表3-1 肝移植受体术前评估表
分数表现 分数表现
昏迷6术中为昏迷状态腹水2难控制型
2ⅢⅣ期昏迷1可控制型
1间歇性意识不清0无
0无肝性脑病其他2胆红素300μmol/L
肌营养不良2重度肌营养不良1曲张静脉出血
1轻度肌营养不良1胆管系统感染
0无肌营养不良1自发性腹膜炎
既往手术史2多次胆管再建手术2年龄大于40岁
2门腔静脉分流术1胆红素100μmol/L
1每次开腹术1PT15 s
0无
本表应用比分累计法,0-3分表示低危病人,如果等于或高于7分,意味着存在着比3分病人高1倍的危险性。单一的因素如术后出血等,与术后病人的存活率也明显相关。既往腹有手术史,特别是胆管手术史,将明显增加手术的难度。
参考文献
1.Feray C,Zignergo AL,Samuel D et al.Persistent hepatitis Bvirus infetion of mononuclear blood cells without concomitant infection.The liver transplantation model.Transplantation,1990,49:1155
2.Pemetris AJ ,Todo S, Van Thiel Dhet al.Evolution of hepatitis B virus liver disease after hepatic replacement.Practical and theoretical consideration.Am J Pathol,1990,137:667
3.O’Grady JG,Willians R.Liver transplantation for viral hepatitis .Br Med Bull.1990,46:481
4.Mazzaferro V,Regalia E,Montalto F et al.Risk of HBV reinfection afeter liver transplantation in HbsAg-positive cirrhosis.Primary hepatocellular carcinoma is not a predictor for HBV recurrence.Liver ,1996,16:117
5.Marsman WA,Wiesher RH,Batts KP et al.Fulminant hepatitis Bvirus:recurrence after liver transplantation in two patients also infected with hepatitis delta virus.Hepatology,1997,25:434
6.Hart J.Busuttil RW,Lewm KJ.Disease recurrence following liver transplantation.Am J Surg Pathol.1990,14(Suppl1):79
7.Martin P,Munoz SJ,DiBisceglia AM et al.Recurrence of hepatitis Cvirus infection after orthotopic liver transplantation.Hepatology,1991,13:719
8.Gane EJ,Portinann BC,Waoumov NV et al .Long-term outcome of hepatitis Cinfection after liver transplantation.N Engl Med,1996,334:815
9.Baber KH,Dalley G,Bahr MJ et al.Long-term outcome of hepatitis C virus infection after liver transplatation .Hepatology,1997,25 :202
10.Terrault NA,Zhou S,Combs Cet al.Prophylaxis in liver transplant recipient using a fixed dosing schedule of hepatitis Bimmunoglobulin.Hepatology,1996,24:1327
11.Van Thiel DH,Bonet H,Gavaler J et al ,Effect of alcohol use on allograft liver transplantation for alcoholic liver disease.Alcohol Chin Exp Res,1995,19:1151
12.Maddrey WC.Bone disease in patients with primary biliary cirrhosis.Prog Liver Dis,1990,9:537
13.Shapiro JM,Smith H,Schaffner F.Serum bilirubin: a prognostic factor in primary biliary cirrhosis.Gut,1979,20:137
14.Mentna G,Giostra E,Rubbia L et al .Follow-up and result of liver transplantation of primary biliary cirrhosis.Swiss Surg,1996,3:116
15.Knoop M,Bechstein Wo,Schrem H et al.Chinical significance of recurrent primary billiary cirrhosis after liver transplantation .Transpl Int,1996,9(Suppl 1):S115
16.Sternlieb I.Wilson’s disease:indication for liver transplantation.Hepatology,1984,4:155
17.Exquive CO,Marino IR,Fioravanti V et al.Liver transplantation formetabolic disease of the liver,Gastroenterol Clin N Am,1988,17:167
18. Ismail T,Angrisani L,Gunson BK et al,Primary hepatic malignancy:The role of liver transplantation,Br J Surg,1990,77:983
19.Hoofnagle JH,Carithevs RC Jr,Shapiro Cet al.Fulminant hepatic failure:summary of a workshop.Hepatology,1995,21:240
20.Williams R,Wendon J.Indication for orthotopic liver transplantation in fulminant liver failure.Hepatology,1994,20:1.
21.Ludwing J,LaRusso NF,Wiesner RH.The syndrome of primary sclerosing cholangitis.Prog Liver Dis,1990,9:555
22 .Rosen CB,Nagorney DM,Wiesner RH et al.Cholangiocarcinoma complicating primary sclerosing cholangitis .Ann Surg,1991,213:21
23.Olsson R,Panielsson ,A,Jarnerot G et al .Prevalence of primary sclerosing cholangitis in patients with ulcerative colitis.Gastroenterology,1991,11:1319
24.Higashi H,Yanaga K,Marsh JW et al.Development of colon cancer after transplantation for primary sclerosing cholangitis associated with ulcerative colitis.Hepatology,1990,11:477
25.Alayoglu M,Stratta RJ,Sollinger HW .Liner transplantation in infans and children.J Pediatr Surg,1989,24:70
26.Salerno F,Borroni G,Moser Pet al .Prognostic value of the galactose test in predicting survival of patients with cirrhosis evaluated for liver transplantation A prospective multicenter Italian study.AISF Group for the Study of Liver Transplantation.Association Italiana per lo Studio del Fegato.Hepatol.1996,25474
相关热词搜索:
论坛新帖
医学推广
热门购物
评论排行
- 2011年临床执业医师考试实践技能真...(13)
- 腋臭手术视频(11)
- 2008年考研英语真题及参考答案(5)
- 节食挑食最伤女人的免疫系统(5)
- 核辐射的定义和单位(5)
- CKD患者Tm与IMT相关(5)
- 齐鲁医院普外科开展“喉返神经监护...(5)
- windows7激活工具WIN7 Activation v1.7(5)
- 正常微循环(5)
- 美大学性教育课来真的 男女上阵亲...(4)